Our Blog

Recce Pharmaceuticals (ASX:RCE) in an agreement with Murdoch Childrens Institute

30 Sep 2020 – Recce Pharmaceuticals (ASX:RCE) has entered into an agreement with the Murdoch Children’s Research Institute to conduct pre-clinical studies assessing the potential of RECCE 435 (R435) for the treatment of Helicobacter pylori infections.


Source: Finance News Network

Share this post